Abstract
Schizophrenia is a neurodevelopmental disorder characterized by complex aberrations in the structure, wiring, and chemistry of multiple neuronal systems. The abnormal developmental trajectory of the brain is established during gestation, long before clinical manifestation of the disease. Over 200 genes and even greater numbers of single nucleotide polymorphisms and copy number variations have been linked with schizophrenia. How does altered function of such a variety of genes lead to schizophrenia? We propose that the protein products of these altered genes converge on a common neurodevelopmental pathway responsible for the development of brain neural circuit and neurotransmitter systems. The results of a multichanneled investigation using induced pluripotent stem cell (iPSCs)- and embryonic stem cell (ESCs)-derived neuronal committed cells (NCCs) indicate an early (preneuronal) developmental-genomic etiology of schizophrenia and that the dysregulated developmental gene networks are common to genetically unrelated cases of schizophrenia. The results support a “watershed” mechanism in which mutations within diverse signaling pathways affect the common pan-ontogenic mechanism, integrative nuclear (n)FGFR1 signaling (INFS). Dysregulation of INFS in schizophrenia NCCs deconstructs coordinated gene networks and leads to formation of new networks by the dysregulated genes. This genome deprograming affects critical gene programs and pathways for neural development and functions. Studies show that the genomic deprograming reflect an altered nFGFR1—genome interactions and deregulation of miRNA genes by nFGFR1. In addition, changes in chromatin topology imposed by nFGFR1 may play a role in coordinate gene dysregulation in schizophrenia.
We dedicate this chapter to Patrick W. Lee whose courage and comradery inspired our work.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 3C:
-
Chromatin conformation capture
- CBP:
-
CREB-binding protein
- ChIPseq:
-
Chromatin immunoprecipitation sequencing
- CNVs:
-
Copy number variations
- ESCs:
-
Embryonic stem cells
- FGFR1(SP-/NLS):
-
Constitutively nuclear active variant of FGFR1
- FGFR1(SP-/NLS)(TK-):
-
Dominant negative nuclear active variant of FGFR1
- GO:
-
Gene ontology
- INFS:
-
Integrative nuclear FGFR1 signaling
- IPA:
-
Ingenuity pathway analysis
- iPSCs:
-
Induced pluripotent stem cells
- NCCs:
-
Neuronal committed cells (integrative nuclear (n)FGFR1 signaling—INFS)
- nFGFR1:
-
Nuclear fibroblast growth factor receptor-1
- RNAseq:
-
Global RNA sequencing
- SNPs:
-
Single nucleotide polymorphisms
- TAD:
-
Chromatin topologically associated domains
References
Akbarian S, Bunney WE Jr, Potkin SG et al (1993) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 50:169–177
Arnold SE, Ruscheinsky DD, Han LY (1997) Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol Psychiatry 42:639–647
Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233. https://doi.org/10.1016/j.cell.2009.01.002
Benes FM, Kwok EW, Vincent SL et al (1998) A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44:88–97
Bharali DJ, Klejbor I, Stachowiak EK et al (2005) Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci USA 102:11539–11544. https://doi.org/10.1073/pnas.0504926102
Blanchard JJ, Kring AM, Horan WP et al (2011) Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophr Bull 37:291–299. https://doi.org/10.1093/schbul/sbq104
Bobbs AS, Saarela AV, Yatskievych TA et al (2012) Fibroblast growth factor (FGF) signaling during gastrulation negatively modulates the abundance of microRNAs that regulate proteins required for cell migration and embryo patterning. J Biol Chem 287:38505–38514. https://doi.org/10.1074/jbc.M112.400598
Bogerts B, Hantsch J, Herzer M (1983) A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry 18:951–969
Brennand KJ, Gage FH (2011) Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia. Stem cells 29:1915–1922. https://doi.org/10.1002/stem.762
Brennand KJ, Simone A, Jou J et al (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221–225. https://doi.org/10.1038/nature09915
Brennand KJ, Landek-Salgado MA, Sawa A (2014a) Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells. Biol Psychiatry 75:936–944. https://doi.org/10.1016/j.biopsych.2013.10.025
Brennand KJ, Silvas J, Kim Y et al (2014b) Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol Psychiatry 20:361–368
Brennand K, Savas JN, Kim Y et al (2015) Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol Psychiatry 20:361–368. https://doi.org/10.1038/mp.2014.22
Cannon TD, Keller MC (2006) Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol 2:267–290. https://doi.org/10.1146/annurev.clinpsy.2.022305.095232
Chiang CH, Su Y, Wen Z et al (2011) Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry 16:358–360. https://doi.org/10.1038/mp.2011.13
Chioni AM, Grose R (2012) FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior. J Cell Biol 197:801–817. https://doi.org/10.1083/jcb.201108077
Ciruna B, Rossant J (2001) FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell 1:37–49. https://doi.org/10.1016/S1534-5807(01)00017-X
Ciruna BG, Schwartz L, Harpal K et al (1997) Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development 124:2829–2841
Claus P, Doring F, Gringel S et al (2003) Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motor neuron protein. J Biol Chem 278:479–485. https://doi.org/10.1074/jbc.M206056200
Coleman SJ, Chioni AM, Ghallab M et al (2014) Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion. EMBO Mol Med 6:467–481. https://doi.org/10.1002/emmm.201302698
Connor SE, Ng V, McDonald C et al (2004) A study of hippocampal shape anomaly in schizophrenia and in families multiply affected by schizophrenia or bipolar disorder. Neuroradiology 46:523–534. https://doi.org/10.1007/s00234-004-1224-0
Davis KL, Stewart DG, Friedman JI et al (2003) White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 60:443–456. https://doi.org/10.1001/archpsyc.60.5.443
Deep-Soboslay A, Benes FM, Haroutunian V et al (2011) Psychiatric brain banking: three perspectives on current trends and future directions. Biol Psychiatry 69:104–112. https://doi.org/10.1016/j.biopsych.2010.05.025
Dekker J, Rippe K, Dekker M et al (2002) Capturing chromosome conformation. Science 295:1306–1311. https://doi.org/10.1126/science.1067799
Dequeant ML, Pourquie O (2008) Segmental patterning of the vertebrate embryonic axis. Nat Rev Genet 9:370–382. https://doi.org/10.1038/nrg2320
Erlenmeyer-Kimling L (2000) Neurobehavioral deficits in offspring of schizophrenic parents: liability indicators and predictors of illness. Am J Med Genet 97:65–71
Fang X, Stachowiak EK, Dunham-Ems SM et al (2005) Control of CREB-binding protein signaling by nuclear fibroblast growth factor receptor-1: a novel mechanism of gene regulation. J Biol Chem 280:28451–28462
Fatemi SH, Folsom TD (2009) The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 35:528–548. https://doi.org/10.1093/schbul/sbn187
Foussias G, Mann S, Zakzanis KK et al (2011) Prediction of longitudinal functional outcomes in schizophrenia: the impact of baseline motivational deficits. Schizophr Res 132:24–27. https://doi.org/10.1016/j.schres.2011.06.026
Francastel C, Schubeler D, Martin DI et al (2000) Nuclear compartmentalization and gene activity. Nat Rev Mol Cell Biol 1:137–143. https://doi.org/10.1038/35040083
Hagege H, Klous P, Braem C et al (2007) Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc 2:1722–1733. https://doi.org/10.1038/nprot.2007.243
Hanzawa S, Bae JK, Bae YJ et al (2013) Psychological impact on caregivers traumatized by the violent behavior of a family member with schizophrenia. Asian J Psychiatry 6:46–51. https://doi.org/10.1016/j.ajp.2012.08.009
Hashimoto-Torii K, Torii M, Fujimoto M et al (2014) Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders. Neuron 82:560–572. https://doi.org/10.1016/j.neuron.2014.03.002
Horbinski C, Stachowiak EK, Chandrasekaran V et al (2002) Bone morphogenetic protein-7 stimulates initial dendritic growth in sympathetic neurons through an intracellular fibroblast growth factor signaling pathway. J Neurochem 80:54–63
Howard R, Rabins PV, Seeman MV et al (2000) Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry 157:172–178. https://doi.org/10.1176/appi.ajp.157.2.172
Hu Y, Fang X, Dunham SM et al (2004) 90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling. J Biol Chem 279:29325–29335. https://doi.org/10.1074/jbc.M311144200
International Schizophrenia Consortium (2008) Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455:237–241. https://doi.org/10.1038/nature07239
Kasper LH, Fukuyama T, Biesen MA et al (2006) Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol Cell Biol 26:789–809. https://doi.org/10.1128/MCB.26.3.789-809.2006
Keshavan MS (1999) Development, disease and degeneration in schizophrenia: a unitary pathophysiological model. J Psychiatr Res 33:513–521
Keshavan MS, Hogarty GE (1999) Brain maturational processes and delayed onset in schizophrenia. Dev Psychopathol 11:525–543
Kirov G, Pocklington AJ, Holmans P et al (2012) De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 17:142–153. https://doi.org/10.1038/mp.2011.154
Kneeland RE, Fatemi SH (2013) Viral infection, inflammation and schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 42:35–48. https://doi.org/10.1016/j.pnpbp.2012.02.001
Lee YW, Terranova C, Birkaya B et al (2012) A novel nuclear FGF receptor-1 partnership with retinoid and Nur receptors during developmental gene programming of embryonic stem cells. J Cell Biochem 113:2920–2936. https://doi.org/10.1002/jcb.24170
Lee YW, Stachowiak EK, Birkaya B et al (2013) NGF-induced cell differentiation and gene activation is mediated by integrative nuclear FGFR1 signaling (INFS). PLoS One 8:e68931. https://doi.org/10.1371/journal.pone.0068931
Lloyd T, Dazzan P, Dean K et al (2008) Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity psychological medicine 38:71–77. https://doi.org/10.1017/S0033291707001158
Malhotra D, McCarthy S, Michaelson JJ et al (2011) High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 72:951–963. https://doi.org/10.1016/j.neuron.2011.11.007
Meshorer E, Misteli T (2006) Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol 7:540–546. https://doi.org/10.1038/nrm1938
Miller BH, Zeier Z, Xi L et al (2012) MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci USA 109:3125–3130. https://doi.org/10.1073/pnas.1113793109
Moreau MP, Bruse SE, David-Rus R et al (2011) Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol Psychiatry 69:188–193. https://doi.org/10.1016/j.biopsych.2010.09.039
Myers JM, Martins GG, Ostrowski J et al (2003) Nuclear trafficking of FGFR1: a role for the transmembrane domain. J Cell Biochem 88:1273–1291
Narla ST, Lee YW, Benson CA et al (2017) Common developmental genome deprogramming in schizophrenia – role of integrative nuclear FGFR1 signaling (INFS). Schizophr Res 185:17–32. https://doi.org/10.1016/j.schres.2016.12.012
Need AC, Attix DK, McEvoy JM et al (2009) A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. Hum Mol Genet 18:4650–4661. https://doi.org/10.1093/hmg/ddp413
Nguyen PT, Tsunematsu T, Yanagisawa S et al (2013) The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1. Br J Cancer 109:2248–2258. https://doi.org/10.1038/bjc.2013.550
Partanen J, Schwartz L, Rossant J (1998) Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev 12:2332–2344
Paulsen BD, Maciel RD, Galina A et al (2011) Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient. Cell Transplant. https://doi.org/10.3727/096368911X600957
Perkins DO, Jeffries CD, Jarskog LF et al (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8:R27. https://doi.org/10.1186/gb-2007-8-2-r27
Popovici C, Fallet M, Marguet D et al (2006) Intracellular trafficking of LET-756, a fibroblast growth factor of C. elegans, is controlled by a balance of export and nuclear signals. Exp Cell Res 312:1484–1495. https://doi.org/10.1016/j.yexcr.2006.01.012
Rajji TK, Ismail Z, Mulsant BH (2009) Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry J Ment Sci 195:286–293. https://doi.org/10.1192/bjp.bp.108.060723
Rehn AE, Rees SM (2005) Investigating the neurodevelopmental hypothesis of schizophrenia. Clin Exp Pharmacol Physiol 32:687–696. https://doi.org/10.1111/j.1440-1681.2005.04257.x
Robicsek O, Karry R, Petit I et al (2013) Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry. https://doi.org/10.1038/mp.2013.67
Rodriguez-Murillo L, Gogos JA, Karayiorgou M (2012) The genetic architecture of schizophrenia: new mutations and emerging paradigms. Annu Rev Med 63:63–80. https://doi.org/10.1146/annurev-med-072010-091100
Roussos P, Guennewig B, Kaczorowski DC et al (2016) Activity-dependent changes in gene expression in schizophrenia human-induced pluripotent stem cell neurons. JAMA Psychiatry 73:1180–1188. https://doi.org/10.1001/jamapsychiatry.2016.2575
Rummel-Kluge C, Komossa K, Schwarz S et al (2012) Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr Bull 38:167–177. https://doi.org/10.1093/schbul/sbq042
Saha S, Chant D, Welham J et al (2005) A systematic review of the prevalence of schizophrenia. PLoS medicine 2:e141. https://doi.org/10.1371/journal.pmed.0020141
Santarelli DM, Beveridge NJ, Tooney PA et al (2011) Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry 69:180–187. https://doi.org/10.1016/j.biopsych.2010.09.030
Schiller D, Zuckerman L, Weiner I (2006) Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol. J Psychiatric Res 40:167–177. https://doi.org/10.1016/j.jpsychires.2005.03.002
Sherman L, Stocker KM, Morrison R et al (1993) Basic fibroblast growth factor (bFGF) acts intracellularly to cause the transdifferentiation of avian neural crest-derived Schwann cell precursors into melanocytes. Development 118:1313–1326
Shi W, Du J, Qi Y et al (2012) Aberrant expression of serum miRNAs in schizophrenia. J Psychiatr Res 46:198–204. https://doi.org/10.1016/j.jpsychires.2011.09.010
Srikanth P, Han K, Callahan DG et al (2015) Genomic DISC1 disruption in hiPSCs alters Wnt signaling and neural cell fate. Cell Rep 12:1414–1429. https://doi.org/10.1016/j.celrep.2015.07.061
Stachowiak MK, Stachowiak EK (2016) Evidence-based theory for integrated genome regulation of ontogeny—an unprecedented role of nuclear FGFR1 signaling. J Cell Physiol 231:1199–1218. https://doi.org/10.1002/jcp.25298
Stachowiak EK, Fang X, Myers J et al (2003) cAMP-induced differentiation of human neuronal progenitor cells is mediated by nuclear fibroblast growth factor receptor-1 (FGFR1). J Neurochem 84:1296–1312
Stachowiak MK, Maher PA, Stachowiak EK (2007) Integrative nuclear signaling in cell development: a role for FGF receptor-1. DNA Cell Biol 26:811–826. https://doi.org/10.1089/dna.2007.0664
Stachowiak EK, Roy I, Lee YW et al (2009a) Targeting novel integrative nuclear FGFR1 signaling by nanoparticle-mediated gene transfer stimulates neurogenesis in the adult brain. Integr Biol (Camb) 1:394–403. https://doi.org/10.1039/b902617g
Stachowiak EK, Roy I, Lee Y-W, Capacchietti M, Aletta JM, Prasad PN, Stachowiak MK (2009b) Targeting novel integrative nuclear FGFR1 signaling by nanoparticle-mediated gene transfer stimulates neurogenesis in adult brain. Integr Biol 1:394–403
Stachowiak EK, Roy I, Stachowiak MK (2011a) Triggering neuronogenesis by endogenous brain stem cells with DNA nanoplexes. In: Stachowiak ES Tzanakakis MK (ed) Stem cells: from mechanisms to technologies. World Scientific Publishing, Hackensack, NJ, pp 333–359
Stachowiak MK, Stachowiak EK, Aletta JM, Tzanakakis ES (2011b) A common integrative nuclear signaling module for stem cell development. In: Stachowiak MK, Tzanakakis ES (eds) Stem cells: from mechanisms to technologies. World Scientific, Hackensack, NJ, pp 87–132
Stachowiak MK, Kucinski A, Curl R et al (2013) Schizophrenia: a neurodevelopmental disorder--integrative genomic hypothesis and therapeutic implications from a transgenic mouse model. Schizophr Res 143:367–376. https://doi.org/10.1016/j.schres.2012.11.004
Stachowiak MK, Birkaya B, Aletta JM et al (2015) Nuclear FGF receptor-1 and CREB binding protein: an integrative signaling module. J Cell Physiol 230:989–1002. https://doi.org/10.1002/jcp.24879
Stachowiak EK, Benson CA, Narla ST et al (2017) Cerebral organoids reveal early cortical maldevelopment in schizophrenia—computational anatomy and genomics, role of FGFR1. Translational Psychiatry 7:6
Stefansson H, Rujescu D, Cichon S et al (2008) Large recurrent microdeletions associated with schizophrenia. Nature 455:232–236. https://doi.org/10.1038/nature07229
Stuhlmiller TJ, Garcia-Castro MI (2012) FGF/MAPK signaling is required in the gastrula epiblast for avian neural crest induction. Development 139:289–300. https://doi.org/10.1242/dev.070276
Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187–1192. https://doi.org/10.1001/archpsyc.60.12.1187
Sun J, Jia P, Fanous AH et al (2010) Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. PLoS One 5:e11351. https://doi.org/10.1371/journal.pone.0011351
Terranova C, Narla ST, Lee YW et al (2015) Global developmental gene programing involves a nuclear form of fibroblast growth factor receptor-1 (FGFR1). PLoS One 10:e0123380. https://doi.org/10.1371/journal.pone.0123380
Topol A, Zhu S, Tran N et al (2015) Altered WNT signaling in human induced pluripotent stem cell neural progenitor cells derived from four schizophrenia patients. Biol Psychiatry 78:e29–e34. https://doi.org/10.1016/j.biopsych.2014.12.028
Vo N, Goodman RH (2001) CREB-binding protein and p300 in transcriptional regulation. J Biol Chem 276:13505–13508. https://doi.org/10.1074/jbc.R000025200
Walsh T, McClellan JM, McCarthy SE et al (2008) Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320:539–543. https://doi.org/10.1126/science.1155174
Welter D, MacArthur J, Morales J et al (2014) The NHGRI GWAS catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42:D1001–D1006. https://doi.org/10.1093/nar/gkt1229
Wen Z, Nguyen HN, Guo Z et al (2014) Synaptic dysregulation in a human iPS cell model of mental disorders. Nature. https://doi.org/10.1038/nature13716
Xu B, Roos JL, Levy S et al (2008) Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40:880–885. https://doi.org/10.1038/ng.162
Yoon KJ, Nguyen HN, Ursini G et al (2014) Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity. Cell Stem Cell 15:79–91. https://doi.org/10.1016/j.stem.2014.05.003
Younger ST, Corey DR (2011) Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res 39:5682–5691. https://doi.org/10.1093/nar/gkr155
Yu DX, Di Giorgio FP, Yao J et al (2014) Modeling hippocampal neurogenesis using human pluripotent stem cells. Stem Cell Rep 2:295–310. https://doi.org/10.1016/j.stemcr.2014.01.009
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Narla, S.T., Decker, B., Sarder, P., Stachowiak, E.K., Stachowiak, M.K. (2018). Induced Pluripotent Stem Cells Reveal Common Neurodevelopmental Genome Deprograming in Schizophrenia. In: Buzanska, L. (eds) Human Neural Stem Cells. Results and Problems in Cell Differentiation, vol 66. Springer, Cham. https://doi.org/10.1007/978-3-319-93485-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-93485-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-93484-6
Online ISBN: 978-3-319-93485-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)